The methylenetetrahydrofolate reductase gene polymorphism in Koreans with coronary artery disease

被引:17
作者
Kim, CH
Hwang, KY
Choi, TM
Shin, WY
Hong, SY
机构
[1] Soonchunhyang Univ, Chunan Hosp, Dept Internal Med, Chunan 330100, Chungnam, South Korea
[2] Soonchunhyang Univ, Sch Med, Dept Prevent Med, Chungnam, South Korea
关键词
coronary artery disease; homocysteine; methylenetetrahydrofolate reductase; polymorphism;
D O I
10.1016/S0167-5273(00)00431-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperhomocysteinemia is a known risk factor of cardiovascular diseases. Methylenetetrahydrofolate reductase (MTHFR), involved in folate-dependant metabolism, is associated with homocysteine levels. We studied the associations among MTHFR genotypes, coronary artery disease (CAD), and homocysteine levels in 85 patients with CAD and 152 healthy subjects. The MTHFR genotypes and plasma homocysteine levels were determined. No significant difference in mutation of the MTHFR gene between two groups was observed (P>0.05). While the homozygous mutant genotype (V/V) had the highest homocysteine levels compared to wild (A/A) and heterozygous mutant (A/V) genotypes. there were no significant differences in homocysteine levels among the MTHFR genotype groups. Homocysteine was significantly and inversely related to folate levels, the significant association in V/V genotype (beta coefficient= - 1.954, P=0.04). Our data suggested that MTHFR polymorphism was not associated with homocysteine levels, implying no association between gene polymorphism and CAD in Koreans. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 16 条
[1]   A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction [J].
Anderson, JL ;
King, GJ ;
Thomson, MJ ;
Todd, M ;
Bair, TL ;
Muhlestein, JB ;
Carlquist, JF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (05) :1206-1211
[2]  
BOCKXMEER FM, 1997, CIRCULATION, V95, P21
[3]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[4]   Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease -: The result of a meta-analysis [J].
Brattström, L ;
Wilcken, DEL ;
Öhrvik, J ;
Brudin, L .
CIRCULATION, 1998, 98 (23) :2520-2526
[5]  
Chen SA, 1998, CIRCULATION, V98, P426
[6]   Common mutation in methylenetetrahydrofolate reductase - Correlation with homocysteine metabolism and late-onset vascular disease [J].
Deloughery, TG ;
Evans, A ;
Sadeghi, A ;
McWilliams, J ;
Henner, WD ;
Taylor, LM ;
Press, RD .
CIRCULATION, 1996, 94 (12) :3074-3078
[7]   A CANDIDATE GENETIC RISK FACTOR FOR VASCULAR-DISEASE - A COMMON MUTATION IN METHYLENETETRAHYDROFOLATE REDUCTASE [J].
FROSST, P ;
BLOM, HJ ;
MILOS, R ;
GOYETTE, P ;
SHEPPARD, CA ;
MATTHEWS, RG ;
BOERS, GJH ;
DENHEIJER, M ;
KLUIJTMANS, LAJ ;
VANDENHEUVEL, LP ;
ROZEN, R .
NATURE GENETICS, 1995, 10 (01) :111-113
[8]  
JANG YS, 1999, KOREAN CIRC J, V29, P135
[9]  
KANG SS, 1991, AM J HUM GENET, V48, P536
[10]   THERMOLABILE DEFECT OF METHYLENETETRAHYDROFOLATE REDUCTASE IN CORONARY-ARTERY DISEASE [J].
KANG, SS ;
PASSEN, EL ;
RUGGIE, N ;
WONG, PWK ;
SORA, H .
CIRCULATION, 1993, 88 (04) :1463-1469